FDA.reportPublic FDA data

Sarcoglycan complex IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of one or multiple types of muscle-specific protein in the sarcoglycan complex in a clinical specimen.
GUDID devices
4
Last updated
2021-07-01 08:38:51

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
05055331309082Novocastra™LEICA BIOSYSTEMS NEWCASTLE LTDG-SARC-CE2021-05-28
05055331310774Novocastra™LEICA BIOSYSTEMS NEWCASTLE LTDD-SARC-CE2021-05-28
05055331316356Novocastra™LEICA BIOSYSTEMS NEWCASTLE LTDB-SARC-L-CE2021-03-12
05055331317100Novocastra™LEICA BIOSYSTEMS NEWCASTLE LTDA-SARC-L-CE2021-03-12